TP53 and in situ carcinoma: Whatever the protocol used, all lesions (dysplasia and in situ carcinomas) were characterized by high expression of LMα1 and LMα5 in the BM and by nuclear accumulation of p53 in the epithelial cells (Figure 4C and Figure S9B).